HomeCompareFRCOY vs MRK

FRCOY vs MRK: Dividend Comparison 2026

FRCOY yields 0.84% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FRCOY wins by $2.60M in total portfolio value· pulled ahead in Year 5
10 years
FRCOY
FRCOY
● Live price
0.84%
Share price
$40.25
Annual div
$0.34
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.66M
Annual income
$2,164,376.76
Full FRCOY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — FRCOY vs MRK

📍 FRCOY pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFRCOYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FRCOY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FRCOY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FRCOY
Annual income on $10K today (after 15% tax)
$71.80/yr
After 10yr DRIP, annual income (after tax)
$1,839,720.25/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, FRCOY beats the other by $1,831,391.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FRCOY + MRK for your $10,000?

FRCOY: 50%MRK: 50%
100% MRK50/50100% FRCOY
Portfolio after 10yr
$1.36M
Annual income
$1,087,087.45/yr
Blended yield
80.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FRCOY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
9.3
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FRCOY buys
0
MRK buys
0
No recent congressional trades found for FRCOY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFRCOYMRK
Forward yield0.84%2.76%
Annual dividend / share$0.34$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$2.66M$56.8K
Annual income after 10y$2,164,376.76$9,798.13
Total dividends collected$2.59M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: FRCOY vs MRK ($10,000, DRIP)

YearFRCOY PortfolioFRCOY Income/yrMRK PortfolioMRK Income/yrGap
1$10,869$168.94$11,206$366.19$337.00MRK
2$11,973$343.22$12,650$502.35$677.00MRK
3$13,518$706.71$14,407$694.19$889.00MRK
4$15,955$1,491.38$16,585$967.82$630.00MRK
5← crossover$20,363$3,290.31$19,342$1,363.89+$1.0KFRCOY
6$29,637$7,848.88$22,913$1,947.19+$6.7KFRCOY
7$53,064$21,352.71$27,662$2,823.89+$25.4KFRCOY
8$128,239$71,460.82$34,159$4,173.35+$94.1KFRCOY
9$460,017$322,800.74$43,337$6,308.80+$416.7KFRCOY
10$2,656,595$2,164,376.76$56,776$9,798.13+$2.60MFRCOY

FRCOY vs MRK: Complete Analysis 2026

FRCOYStock

Fast Retailing Co., Ltd., through its subsidiaries, operates as an apparel designer and retailer in Japan and internationally. The company operates through four segments: UNIQLO Japan, UNIQLO International, GU, and Global Brands. It manufactures and retails clothing for men, women, children, and babies; and lingerie, as well as other goods and items. The company operates stores and franchises under the UNIQLO, GU, PLST, Theory, COMPTOIR DES COTONNIERS, J Brand, and PRINCESSE TAM.TAM brand names. It also sells its products through online; and provides real estate leasing services. The company was formerly known as Ogori Shoji Co., Ltd. and changed its name to Fast Retailing Co., Ltd. in September 1991. Fast Retailing Co., Ltd. was founded in 1949 and is headquartered in Yamaguchi, Japan.

Full FRCOY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FRCOY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FRCOY vs SCHDFRCOY vs JEPIFRCOY vs OFRCOY vs KOFRCOY vs MAINFRCOY vs JNJFRCOY vs ABBVFRCOY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.